NZ313874A - Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus - Google Patents

Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus

Info

Publication number
NZ313874A
NZ313874A NZ313874A NZ31387496A NZ313874A NZ 313874 A NZ313874 A NZ 313874A NZ 313874 A NZ313874 A NZ 313874A NZ 31387496 A NZ31387496 A NZ 31387496A NZ 313874 A NZ313874 A NZ 313874A
Authority
NZ
New Zealand
Prior art keywords
group
eliminating
patient
diabetes mellitus
dependent diabetes
Prior art date
Application number
NZ313874A
Inventor
Randall W Whitcomb
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NZ313874A publication Critical patent/NZ313874A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The use, in the manufacture of a medicament for eliminating the need for exogenous insulin administered to a patient having non-insulin dependent diabetes mellitus, of a compound of the above formula, wherein: R1 and R2 are the same or different and each represents a hydrogen atom or a C1-C5 alkyl group; R3 represents a hydrogen atom, a C1-C6 aliphatic acyl group, an alicyclic acyl group, an aromatic acyl group, a heterocyclic acyl group, an araliphatic acyl group, a (C1-C6 alkoxy)carbonyl group, or an aralkyloxycarbonyl group; R4 and R5 are the same or different and each represents a hydrogen atom, a C1-C5 alkyl group or a C1-C5 alkoxy group, or R4 and R5 together represent a C1-C4 alkylenedioxy group; n is 1, 2, or 3; W represents the -CH2-, CO, or CH-OR6 group (in which R6 represents any one of the atoms or groups defined for R3 and may be the same as or different from R3); and Y and Z are the same or different and each represents an oxygen atom or an imino (=NH) group;
NZ313874A 1995-08-10 1996-07-29 Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus NZ313874A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US209895P 1995-08-10 1995-08-10
PCT/US1996/012430 WO1997005875A2 (en) 1995-08-10 1996-07-29 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
NZ313874A true NZ313874A (en) 2000-09-29

Family

ID=21699238

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ313874A NZ313874A (en) 1995-08-10 1996-07-29 Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus

Country Status (15)

Country Link
EP (1) EP0851757A2 (en)
JP (1) JPH11510508A (en)
KR (1) KR19990036290A (en)
CN (1) CN1192683A (en)
AU (1) AU724989B2 (en)
BG (1) BG102235A (en)
CA (1) CA2221241A1 (en)
CZ (1) CZ32998A3 (en)
EA (1) EA199800177A1 (en)
HU (1) HUP9802543A2 (en)
IL (1) IL122191A0 (en)
NO (1) NO980556L (en)
NZ (1) NZ313874A (en)
SK (1) SK16498A3 (en)
WO (1) WO1997005875A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
GB2335597A (en) * 1998-03-27 1999-09-29 Glaxo Group Ltd Stereoisomers of Troglitazone in the Treatment of Diabetes
FR2838968A1 (en) * 2002-04-30 2003-10-31 Lipha ASSOCIATION OF INSULIN AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR TREATING DIABETES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (en) * 1983-08-30 1985-03-22 Sankyo Co Ltd Thiazolidine derivative and its preparation
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
WO1997005875A2 (en) 1997-02-20
CZ32998A3 (en) 1998-10-14
HUP9802543A2 (en) 1999-07-28
AU724989B2 (en) 2000-10-05
WO1997005875A3 (en) 1997-03-27
CA2221241A1 (en) 1997-02-20
JPH11510508A (en) 1999-09-14
AU6641196A (en) 1997-03-05
IL122191A0 (en) 1998-04-05
KR19990036290A (en) 1999-05-25
SK16498A3 (en) 1999-03-12
CN1192683A (en) 1998-09-09
EP0851757A2 (en) 1998-07-08
EA199800177A1 (en) 1998-10-29
NO980556D0 (en) 1998-02-09
BG102235A (en) 1998-09-30
NO980556L (en) 1998-02-09

Similar Documents

Publication Publication Date Title
ATE33838T1 (en) THIAZOLIDE DERIVATIVES, THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM.
HUP0203165A2 (en) 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
EP0645387A4 (en)
CA2168751A1 (en) Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
HUT57710A (en) Process for producing amidine and guanidine derivatives and pharmaceutical compositions comprising such active ingredient
UA41268C2 (en) Clear syringe
DE59410181D1 (en) NEW THIAZOLIDE INDIONS AND MEDICINAL PRODUCTS CONTAINING THEM
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
HUP0203431A2 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
HK1005591A1 (en) D'aryl-3 oxazolidinone derivatives method of preparation and therapeutic application
ZA935340B (en) Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity
AU8824391A (en) New guanidine compounds, process for preparing these and pharmaceutical compositions containing them
NZ313874A (en) Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
KR890016017A (en) Substituted 1- (1H-imidazol-4-yl) alkyl-benzamide
EP0436734A4 (en) New aminopiperazine derivatives
MXPA03010867A (en) Novel heterocyclic derivatives and medicinal use thereof.
IE862768L (en) Flavone derivatives
ES8603404A1 (en) Penem derivatives and precursors.
ES8505231A1 (en) Composition active against mites, whitefly and thrips, pharmaceutical composition, and new benzoylureau compounds.
AU7916394A (en) Dithiocarbonimide derivative, fungicidal/insecticidal/ acaricidal agent containing said derivative as active ingredient, intermediate for use in production of said derivative and process for producing said derivative from said intermediate
YU94003A (en) Novel heterocyclic compound and medicinal use thereof
GEP20002212B (en) Clavulanic Acid and Diamino Ether Derivatives, Di-Clavulanate Salt, Method for Its Production and Pharmaceutical Composition on Its Basis
KR890013192A (en) Teicoplanin hydrazide
HUP0001443A2 (en) 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds, pharmaceutical compositions thereof and process for preparing them
DK0504807T3 (en) Use of bis (p-hydroxyphenylthio) methane derivatives to inhibit progressive development of insulin-dependent diabetes mellitus